Aora Health Attends NACFC 2024

Aora Health's dedication to improving the lives of patients with Cystic Fibrosis (CF)has been always on target. In October 2024 our esteemed Technical Director, Miguel Ángel Pozas, presented Enzymax Forte, an exceptional alternative treatment option for CF patients, in the official North America Cystic Fibrosis Congress in Boston (NACFC), USA Enzymax Forte, a new generation of pancreatic enzyme replacement therapy (PERT), has been rigorously studied and backed by extensive clinical evidence.

Its advanced formulation offers superior digestive support, enabling CF patients to better absorb essential nutrients and maintain optimal health. By attending this influential congress, Aora Health reinforced its position as a leader in innovative healthcare solutions.

Our commitment to providing high-quality, science-based treatments for CF patients remains unwavering. We are proud to offer Enzymax Forte as a valuable tool in the management of this complex condition.